Th1 and Th2 subsets of T lymphocytes: Characteristics, physiological role and regulation;Les sous-populations de lymphocytes Th1 et Th2: Caracterisation, role physiologique et regulation

Bulletin de l'Institut Pasteur

Volumn 94, Issue 3, 1996, Pages 173-200

  Sedlik, C ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

review; subsets, physiological role, regulation; T lymphocyte, Th1, Th2, cytokine

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 4;

CELL DIFFERENTIATION; HUMAN; PHYSIOLOGY; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030186130     PISSN: 00202452     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-2452(97)86016-2     Document Type: Review

References (221)

1. [1] Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. (1986), Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136, 2348-2357.
2. + T lymphocytes. Immunol. Today, 9, 268-274.
3. [3] Scott, P., Natovit, P., Coffman, R.L., Pearce, E. & Sher, A. (1988), Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med., 168, 1675-1684.
4. [4] Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L. & Locksley, R.M. (1989), Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine Leishmaniasis. J. Exp. Med., 169, 59-72.
5. + T lymphocytes in atopic patients. J. Immunol., 144, 4651-4656.
6. [6] Salgame, P., Abrams, J.S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R.L. & Bloom, B.R. (1991), Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science, 254, 279-282.
7. [7] Yamamura, M., Uyemura, K., Deans, R.J., Weinberg, K., Rea, T.H., Bloom, B.R. & Modlin, R.L. (1991), Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science, 254, 277-279.
8. [8] Del Prete, G.F., De Carli, M., Mastromauro, C., Biagiotti, R., Macchia, D., Falagiani, P., Ricci, M. & Romagnani, S. (1991), Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest., 88, 346-350.
9. [9] Cherwinski, H.M., Schumacher, J.H., Brown, K.D. & Mosmann, T.R. (1987), Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med., 166, 1229-1244.
10. [10] Coffman, R.L. & Carty, J. (1986), A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J. Immunol., 136, 949-954.
11. [11] Snapper, C.M. & Paul, W.E. (1987), Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science, 236, 944-947.
12. [12] Finkelman, F.D., Katona, I.M., Mosmann, T.R. & Coffman, R.L. (1988), IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol., 140, 1022-1027.
13. [13] Stevens, T.L., Bossie, A., Sanders, V.M., Fernandez-Botran, R., Coffman, R.L., Mosmann, T.R. & Vitetta, E.S. (1988), Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature (Lond.), 334, 255-258.
14. [14] Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R.M. & Aguet, M. (1993), Immune response in mice that lack the interferon-γ receptor. Science, 259, 1742-1745.
15. [15] van Ommen, R., Vredendaal, A.E.C.M. & Savelkoul, H.F.J. (1994), Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo. Eur. J. Immunol., 24, 1396-1403.
16. [16] Kühn, R., Rajewsky, K. & Müller, W. (1991), Generation and analysis of interleukin-4 deficient mice. Science, 254, 707-710.
17. [17] Kopf, M., Gros, G.L., Bachmann, M., Lamers, M.C., Bluethmann, H. & Köhler, G. (1993), Disruption of the murine IL4 gene blocks Th2 cytokine responses. Nature (Lond.), 362, 245-248.
18. [18] Vajdy, M., Kosco-Vilbois, M.H., Kopf, M., Köhler, G. & Lycke, N. (1995), Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med., 181, 41-53.
19. [19] Murray, P.D., McKenzie, D.T., Swain, S.L. & Kagnoff, M.F. (1987), Interleukin 5 and interleukin 4 produced by Payer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol., 139, 2669-2674.
20. [20] Harriman, G.R., Kunimoto, D.Y., Elliott, J.F., Paetkau, V. & Strober, W. (1988), The role of IL-5 in IgA B cell differentiation. J. Immunol., 140, 3033-3039.
21. [20 bis] Coffman, R.L., Lebman, D.A., Shrader, B. (1989), Transforming growth factor-β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med., 170, 1039-1044.
22. [21] Punnonen, J., Aversa, G., Cocks, B.G., McKenzie, A.N.J., Menon, S., Zurawski, G., de Waal Malefyt, R. & de Vries, J.A. (1993), Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA, 90, 3730-3734.
23. [22] Defrance, T., Carayon, P., Billian, G., Guillemot, J.-C., Minty, A., Caput, D. & Ferrara, P. (1994), Interleukin 13 is a B cell stimulating factor. J. Exp. Med., 179, 135-143.
24. [23] Cher, D.J. & Mosmann, T.R. (1987), Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol., 138, 3688-3694.
25. [24] Maggi, E., Parronchi, P., Simonelli, R.M., Piccinni, M.P., Rugiu, F.S., De Carli, M., Ricci, M. & Romagnani, S. (1992), Reciprocal regulatory effects of IFN-γ and IL4 on the in vitro development of human Th1 and Th2 clones. J. Immunol., 148, 2142-2147.
26. [25] Fernandez-Botran, R., Sanders, V.M., Mosmann, T.R. & Vitetta, E.S. (1988), Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J. Exp. Med., 168, 543-558.
27. [26] Gajewski, T.F., Joyce, J. & Fitch, F.W. (1988), Anti-proliferative effect of IFNγ in immune regulation. I. IFNγ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol., 140, 4245-4252.
28. [27] Fiorentino, D.F., Bond, M.W. & Mosmann, T.R. (1989), Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 170, 2081-2095.
29. [28] Fiorentino, D.F., Zlotnik, A., Vieira, P., Mosmann, T.R., Howard, M., Moore, K.W. & O'Garra, A. (1991), IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol., 146, 3444-3451.
30. [29] Hsieh, C.-S., Heimberger, A.B., Gold, J.S., O'Garra, A. & Murphy, K.M. (1992), Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Sci. Acad. USA, 89, 6065-6069.
31. [30] Ding, L., Linsley, P.S., Huang, L.Y., Germain, R.N. & Shevach, E.M. (1993), IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol., 151, 1224-1234.
32. [31] Chen, Y., Kuchroo, V.K., Inobe, J.I., Hafler, D.A. & Weiner, H.L. (1994), Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science, 265, 1237-1240.
33. [32] Kelso, A. & Gough, N.M. (1988), Coexpression of granulocyte-macrophage colony-stimulating factor, γ interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones. Proc. Natl. Acad. Sci. USA, 85, 9189-9193.
34. + T cell clones. J. Immunol., 141, 849-855.
35. + cell subsets in mice as revealed by single-cell cytokine analysis. Eur. J. Immunol., 24, 549-557.
36. + T cell subset with an unrestricted cytokine profile. J. Immunol., 143, 518-525.
37. + T cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion. Eur. J. Immunol., 25, 1298-1305.
38. [37] Street, N.B., Schumacher, J.H., Fong, A.T., Bass, H., Fiorentino, D.F., Leverah, J.A. & Mosmann, T.R. (1990), Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J. Immunol., 144, 1629-1639.
39. - helper cells that secretes interleukin 2 (IL2), IL-3, IL4, and interferon γ. J. Exp. Med., 174, 547-559.
40. [39] Abehsira-Amar, O., Gibert, M., Joliy, M., Theze, J. & Jankovic, D.L. (1994), IL4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J. Immunol., 148, 3820-3829.
41. [40] Swain, S.L., McKenzie, D.T., Weinberg, A.D. & Hancock, W. (1988), Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J. Immunol., 141, 3445-3455.
42. + T cells producing IL2 or IL4. J. Immunol., 148, 1031-1036.
43. [42] Sad, S. & Mosmann, T.R. (1994), Single IL2 secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol., 3514-3522.
44. - and IFNγ-producing T cells studied by lineage ablation of IL4-producing cells. Cell, 75, 985-995.
45. + T cell clones secrete the Th1 pattern of cytokines. J. Immunol., 144, 1744-1752.
46. + T cells. Infect. Immun., 61, 3730-3738.
47. + T cells following secondary infection of mice immune to Leishmania major. Infect. Immun., 62, 2575-2581.
48. + T cells can be primed in vitro to produce IL4. J. Immunol., 148, 1652-1656.
49. [48] Croft, M., Carter, L., Swain, S.L. & Dutton, R.W. (1994), Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med., 180, 1715-1728.
50. + T cells secreting Th1 or Th2 cytokines. Immunity, 2, 271-279.
51. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med., 180, 489-495.
52. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA, 90, 948-952.
53. - cells that make Th2 cytokines and help B cells. Science, 260, 1802-1805.
54. [53] Pfeifer, J.D., McKenzie, D.T., Swain, S.L. & Dutton, R.W. (1987), B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J. Exp. Med., 166, 1464-1470.
55. [54] Widmer, M.B. & Grabstein, K.H. (1987), Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature (Lond.), 326, 795-798.
56. [55] Horohov, D.W., Crim, J.A., Smith, P.L. & Siegel, J.P. (1988), IL4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J. Immunol., 141, 4217-4223.
57. [56] Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trentham, D.E. & Hafler, D.A. (1994), Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol., 12, 809-837.
58. + memory T cells secrete T helper type 1 and type 2 cytokines and provide help for immunoglobulin secretion. Eur. J. Immunol., 24, 3087-3092.
59. + T cell clones can provide B cell help. J. Immunol., 154, 3118-3127.
60. [59] Mosmann, T.R. & Sad, S. (1996), The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today, 17, 138-146.
61. [60] Boom, W.H., Liebster, L., Abbas, A.K. & Titus, R.G. (1990), Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun., 58, 3863-3870.
62. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA, 88, 7011-7015.
63. [62] Sadick, M.D., Heinzel, F.P., Holaday, B.J., Pu, R.T., Dawkins, R.S. & Locksley, R.M. (1990), Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J. Exp. Med., 171, 115-127.
64. [63] Chatelain, R., Varkila, K. & Coffman, R.L. (1992), IL4 induces a Th2 response in Leishmania major-infected mice. J. Immunol., 148, 1182-1187.
65. [64] Belosevic, M., Finbloom, D.S., van der Meide, P.H., Slayter, M.V. & Nacy, C.A. (1989), Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol., 143, 266-274.
66. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med., 179, 1367-1371.
67. [66] Scott, P., Pearce, E., Natovitz, P. & Sher, A. (1987), Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfraction of a soluble promastigote extract. J. Immunol., 139, 3118-3125.
68. [67] Jardim, A., Alexander, J., Teh, H.S., Ou, D. & Olafson, R.W. (1990), Immunoprotective Leishmania major synthetic T cell epitopes. J. Exp. Med., 172, 645-648.
69. [68] Liew, F.Y., Millott, S., Parkinson, C., Palmer, R.M.J. & Moncada, S. (1990), Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol., 144, 4794-4797.
70. [69] Trinchieri, G. (1994), Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84, 4008-4027.
71. [70] Heinzel, F.P., Schoenhaut, D.S., Rerko, R.M., Rosser, L.E. & Gately, M.K. (1993), Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med., 177, 1505-1509.
72. [71] Sypek, J.P., Chung, C.L., Mayor, S.E.H., Subramanyam, J.M., Goldman, S.J., Sieburth, D.S., Wolf, S.F. & Schaub, R.G. (1993), Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med., 177, 1797-1802.
73. [72] Mougneau, E., Altare, F., Wakil, A.E., Zheng, S., Coppola, T., Wang, Z.-E., Waldmann, R., Locksley, R.M. & Glaichenhaus, N. (1995), Expression cloning of a protective Leishmania antigen. Science, 268, 563-566.
74. + T cell response. J. Exp. Med., 181, 961-971.
75. [74] Noben-Trauth, N., Kropf, P. & Müller, I. (1996), Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science, 271, 987-990.
76. [75] Marx, J. (1996), Leishmania susceptibility puzzle gets another twist. Science, 271, 912-913.
77. [76] Güler, M.L., Gorham, J.D., Hsieh, C.-S., Mackey, A.J., Steen, R.G., Dietrich, W.F. & Murphy, K.M. (1996), Genetic susceptibility to Leishmania: IL12 responsiveness in Th1 cell development. Science, 271, 984-987.
78. + Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol., 148, 2283-2290.
79. + T cells in vivo. J. Immunol., 151, 1391-1400.
80. [79] Wynn, T.A., Eltoum, I., Cheever, A.W., Lewis, F.A., Gause, W.C. & Sher, A. (1993), Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol., 151, 1430-1440.
81. + T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections. Immunology, 67, 466-472.
82. [81] Cheever, A.W., Williams, M.E., Wynn, T.A., Finkelman, F.D., Seder, R.A., Cox, T.M., Hieny, S., Caspar, P. & Sher, A. (1994), Anti-IL4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol., 153, 753-759.
83. [82] Gazzinelli, R.T., Oswald, I.P., James, S.L. & Sher, A. (1992), IL-10 inhibits parasite killing and nitrogen oxide production by IFNγ-activated macrophages. J. Immunol., 148, 1792-1796.
84. [83] Pearce, E.J., Caspar, P., Grzych, J.M., Lewis, F.A. & Sher, A. (1991), Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med., 173, 159-166.
85. [84] Reed, S.G. (1988), In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol., 140, 4342-4347.
86. [85] Reed, S.G., Russo, C.E.B.M., Silva, J.S., Grabstein, K.H. & Morrissey, P.J. (1994), IL-10 mediates susceplibility to Trypanosoma cruzi infection. J. Immunol., 153, 3135-3140.
87. [86] Urban Jr., J.F., Madden, K.B., Cheever, A.W., Trotta, P.P., Katona, I.M. & Finkelman, F.D. (1993), IFN inhibits inflammatory responses and protective immunity in mice infected with the nematode parasite, Nippostrongylus brasiliensis. J. Immunol., 151, 7086-7094.
88. [87] Else, K.J., Finkelman, F.D., Maliszewski, C.R. & Grencis, R.K. (1994), Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med., 179, 347-351.
89. [88] Urban Jr., J.F., Katona, I.M., Paul, W.E. & Finkelman, F.D. (1991), Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc. Natl. Acad. Sci USA, 88, 5513-5517.
90. [89] Urban, J.F.J., Maliszewski, C.R., Madden, K.B., Katona, I.M. & Finkelman, F.D. (1995), IL4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. J. Immunol., 154, 4675-4684.
91. [90] Pirmez, C., Yamamura, M., Uyemura, K., Paes-Oliveira, M., Conceiçao-Silva, F. & Modlin, R.L. (1993), Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest., 91, 1390-1395.
92. [91] Limaye, A.P., Abrams, J.S., Silver, J.E., Ottesen, E.A. & Nutman, T.B. (1990), Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J. Exp. Med., 172, 399-402.
93. [92] Mahanty, S., Abrams, J.S., King, C.L., Limaye, A.P. & Nutman, T.B. (1992), Parallel regulation of IL4 and IL-5 in human helminth infections. J. Immunol., 148, 3567-3571.
94. [93] Cooper, A.M., Dalton, D.K., Stewart, T.A., Griffin, J.P., Russell, D.G. & Orme, I.M. (1993), Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med., 178, 2243-2247.
95. [94] Walker, K.B., Butler, R. & Colston, M.J. (1992), Role of Th1 lymphocytes in the development of protective immunity against Mycobacterium leprae. Analysis of lymphocyte function by polymerase chain reaction detection of cytokine messenger RNA. J. Immunol., 148, 1885-1889.
96. [95] Haanen, J.B.A.G., de Waal Malefijt, R., Res, P.C.M., Kraakman, E.M., Ottenhoff, T.H.M., De Vries, R.R.P. & Spits, H. (1991), Selection of a human T helper type 1-like T cell subset by Mycobacteria. J. Exp. Med., 174, 583-592.
97. [96] Haak-Frendscho, M., Brown, J.F., Iizawa, Y., Wagner, R.D. & Czuprynski, C.J. (1992), Administration of anti-IL4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocylogenes infection. J. Immunol., 148, 3978-3985.
98. [97] Yssel, H., Shanafelt, M.C., Soderberg, C., Schneider, P.V., Anzola, J. & Peltz, G. (1991), Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med., 174, 593-601.
99. [98] Lahesmaa, R., Yssel, H., Batsford, S., Luukkainen, R., Mötiönen, T., Steinman, L. & Peltz, G. (1992), Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J. Immunol., 148, 3079-3085.
100. [99] Matyniak, J.E. & Reiner, S.L. (1995), T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med., 181, 1251-1254.
101. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined suceptibility or vaccine-induced resistance. J. Immunol., 150, 925-931.
102. [101] Huber, S.A. & Pfaeffle, B. (1994), Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol., 68, 5126-5132.
103. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med., 180, 1273-1282.
104. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med., 181, 1285-1292.
105. [104] Clerici, M., Lucey, D.R., Berzofsky, J.A., Pinto, L.A., Wynn, T.A., Blatt, S.P., Dolan, M.J., Hendrix, C.W., Wolf, S.F. & Shearer, G.M. (1993), Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science, 262, 1721-1724.
106. [105] Clerici, M. & Shearer, G.M. (1993), A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today, 14, 107-110.
107. [106] Graziosi, C., Pantaleo, G., Gantt, K.R., Fortin, J.P., Demarest, J.F., Cohen, O.J., Sékaly, R.P. & Fauci, A.S. (1994), Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science, 265, 248-252.
108. [107] Maggi, E., Mazzetti, M., Ravina, A., Annunziato, F., De Carli, M., Piccinni, M.P., Manetti, R., Carbonari, M., Pesce, A.M., Del Prete, G. & Romagnani, S. (1994), Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and ThO cells. Science, 265, 244-267.
109. [108] Coutelier, J.P., van der Logt, J.T.M., Heessen, F.W.A., Vink, A. & Van Snick, J. (1988), Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med., 168, 2373-2378.
110. [109] Coutelier, J.P., van der Logt, J.T.M. & Heessen, F.W.A. (1991), IgG subclass distribution of primary and secondary immune responses concomitant with viral infection. J. Immunol., 147, 1383-1386.
111. [110] Del Prete, G., Maggi, E., Parronchi, P., Chrétien, I., Tin, A., Macchia, D., Ricci, M., Banchereau, J., de Vries, J. & Romagnani, S. (1988), IL4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants, J. Immunol., 140, 4193-4198.
112. [111] Parronchi, P., Macchia, D., Piccinni, M.-P., Biswas, P., Simonelli, C., Maggi, E., Ricci, M., Ansari, A.A. & Romagnani, S. (1991), Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA, 88, 4538-4542.
113. [112] Carballido, J.M., Carballido-Perrig, N., Terres, G., Heusser, C.H. & Blaser, K. (1992), Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Eur. J. Immunol., 22, 1357-1363.
114. + T cell clones. J. Immunol., 148, 738-745.
115. [114] Maggi, E., Biswas, P., Del Prete, G., Parronchi, P., Macchia, D., Simonelli, C., Emmi, L., De Carli, M., Tin, A., Ricci, M. & Romagnani, S. (1991), Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol., 146, 1169-1174.
116. [115] Hamid, Q., Azzawi, M., Ying, S., Moqbel, R., Wardlaw, A.J., Corrigan, C.J., Bradley, B., Durham, S.R., Collins, J.V., Jeffery, P.K., Quint, D.J. & Kay, A.B. (1991), Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest., 87, 1541-1546.
117. [116] Robinson, D.S., Hamid, Q., Ying, S., Tscicopoulos, A., Barkans, J., Bentley, A.M., Corrigan, C., Durham, S.R. & Kay, B. (1992), Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 326, 298-304.
118. [117] Durham, S.R., Ying, S., Varney, V.A., Jacobson, M.R., Sudderick, R.M., Mackay, I.S., Kay, A.B. & Hamid, Q.A. (1992), Cytokine messenger RNA expression for IL-3, IL4, IL-5 and granulocyte/ macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol., 148, 2390-2394.
119. [118] Bradding, P., Feather, I.H., Wilson, S., Bardin, P.G., Heusser, C.H., Holgate, S.T. & Howarth, P.H. (1993), Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J. Immunol., 151, 3853-3865.
120. [119] Del Prete, G.F., De Carli, M., D'Elios, M.M., Maestrelli, P., Ricci, M., Fabbri, L. & Romagnani, L. (1993), Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol., 23, 1445-1449.
121. + T cells from allergic individuals. J. Exp. Med., 178, 2123-2130.
122. [121] Merrill, J.E., Kono, D.H., Clayton, J., Ando, D.G., Hinton, D.R. & Hofman, F.M. (1991), Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci USA, 89, 574-578.
123. [122] van der Veen, R.C., Kapp, J.A. & Trotter, J.L. (1993), Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells. J. Neuroimmunol., 48, 221-226.
124. [123] Rott, O., Cash, E. & Fleischer, B. (1993), Phosphodiesterase inhibitor pentoxifylline, a selective suppresser of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol., 23, 1745-1751.
125. [124] Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D. & Rott, O. (1994), Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol., 153, 4258-4267.
126. [125] Kaufman, D.L., Clare-Salzier, M., Tian, J., Forsthuber, T., Ting, G.S.P., Robinson, P., Atkinson, M.A., Sercarz, E.E., Tobin, A.J. & Lehmann, P.V. (1993), Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.), 366, 69-72.
127. [126] Rapoport, M.J., Jaramillo, A., Zipris, D., Lazarus, A.H., Serreze, D.V., Leiter, E.H., Cyopick, P., Danska, J.S. & Delovitch, T.L. (1993), Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med., 178, 87-99.
128. [127] Katz, J.D., Benoist, C. & Mathis, D. (1995), T helper cell subsets in insulin-dependent diabetes. Science, 268, 1185-1188.
129. [128] Moritani, M., Yoshimoto, K., Tashiro, F., Hashimoto, C., Miyazaki, J.-I., Li, S., Kudo, E., Iwahana, H., Hayashi, Y., Sano, T. & Itakura, M. (1994), Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in nonobese diabetic mice. Int. Immunol., 6, 1927-1936.
130. [129] Lee, M.S., Wogensen, L., Shizuru, J., Oldstone, M.B. & Sarvetnick, N. (1994), Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest., 93, 1332-1338.
131. [130] Skeiky, Y.A.W., Guderian, J.A., Benson, D.R., Bacelar, O., Carvalho, E.M., Kubin, M., Badaro, R., Trinchieri, G. & Reed, S.G. (1995), A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J. Exp. Med., 181, 1527-1537.
132. + T cells. J. Immunol., 146, 577-584.
133. [132] Evavold, B.D., Willimas, S.G., Hsu, B.L., Buus, S. & Allen, P.M. (1992), Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol., 148, 347-353.
134. + T cells from T cell receptor transgenic mice. J. Exp. Med., 176, 1091-1098.
135. [134] Soloway, P., Fish, S., Passmore, H., Gefter, M., Coffee, R. & Manser, T. (1991), Regulation of the immune responses to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J. Exp. Med., 174, 847-858.
136. [135] Murray, J.S., Ferrandis-Edwards, D., Wolfe, C.J. & Schountz, T. (1994), Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density. Eur. J. Immunol., 24, 2337-2344.
137. [136] Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A. & Bottomly, K. (1995), Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med., 181, 1569-1574.
138. [137] Kumar, V., Bhardwaj, V., Scares, L., Alexander, J., Sette, A. & Sercarz, E. (1995), Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon γ by T cells. Proc. Natl. Acad. Sci. USA, 92, 9510-9514.
139. [138] Singh, R.R., Kumar, V., Ebling, F.M., Southwood, S., Sette, A., Sercarz, E.E. & Hahn, B.H. (1995), T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med., 181, 2017-2027.
140. [139] Haraguchi, S., Good, R.A., James-Yarish, M., Cianciolo, G.J. & Day, N.K. (1995), Differential modulation cf Th1-and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA, 92, 3611-3615.
141. [140] Parish, C.R. & Liew, F.Y. (1972), Immune response to chemically modified flagellin. III. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J. Exp. Med., 299-311.
142. [141] Bretscher, P.A., Wei, G., Menon, J.N. & Bielefeldt-Ohmann, H. (1992), Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science, 257, 539-542.
143. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med., 181, 1081-1089.
144. [143] Kolbe, L., Heusser, C.H. & Kölsch, E. (1995), Isotype-associated recognition of allergen epitopes and its modulation by antigen dose. Immunology, 84, 285-289.
145. + T cells. J. Exp. Med., 182, 1591-1596.
146. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med., 182, 1579-1584.
147. [146] Guéry, J.C., Galbiati, F., Smiroldo, S. & Adorini, L. (1996), Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. J. Exp. Med., 183, 485-497.
148. [147] Hayglass, K.T. & Stefura, B.P. (1991), Anti-interferon γ treatment blocks the ability of glutaraldehydepolymerized allergens to inhibit specific IgG responses. J. Exp. Med., 173, 279-285.
149. [148] De Wit, D., Mechelen, M.V., Ryelandt, m., Figueiredo, A.C., Abramowicz, D., Goldman, M., Bazin, H., Urbain, J. & Leo, O. (1992), The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T-helper type 1 but not type 2 lymphocytes. J. Exp. Med., 175, 9-14.
150. [149] Xu-Amano, J., Aicher, W.K., Taguchi, T., Kiyono, H. & McGhee, J.R. (1991), Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol., 4, 433-445.
151. [150] Xu-Amano, J., Jackson, R.J., Fujihashi, K., Kiyono, H., Staats, H.F. & McGhee, J.R. (1994), Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine, 12, 903-911.
152. [151] Andersson, M. & Acha-Orbea, H. (1994), The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern. Immunology, 83, 438-443.
153. [152] Barnard, A., Mahon, B.P., Watkins, J., Redhead, K. & Mills, K.H.G. (1996), Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of cell subsets as Th1, Th2 or Th0. Immunology, 87, 372-380.
154. [153] Yang, X. & Hayglass, K.T. (1993), Allergen-dependent induction of interleukin-4 synthesis in vivo. Immunology, 78, 74-79.
155. [154] Valensi, J.-P.M., Carlson, J.R. & Nest, G.A.V. (1994), Systemic cytokine profiles in BALB/c mice immunized with trivalent Influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol., 153, 4029-4039.
156. [155] Ma, J., Bulger, P.A., Davis, D.R., Perilli-Palmer, B., Bedore, D.A., Kensil, C.R., Young, E.M., Hung, C.H., Seals, J.R., Pavia, C.S. & Coughlin, R.T. (1994), Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi. Vaccine, 12, 925-932.
157. [156] Villacres-Eriksson, M. (1995), Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin, Exp. Immunol., 102, 46-52.
158. + T cell responses by oral or parenteral immunization with ISCOMS. Eur. J. Immunol., 25, 2835-2841.
159. [158] Rhodes, J., Chen, H., Hall, S.R., Beesley, J.E., Jenkins, D.C., Collins, P. & Zheng, B. (1995), Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature (Lond.), 377, 71-75.
160. [159] Tamura, M., Saito, S. & Sasakawa, S. (1985), Induction of human interferon γ in nylon-column nonadherent human lymphocyte cells by heat-treated polyI: polyC. J. Interferon. Res., 5, 77-84.
161. [160] Manetti, R., Annunziato, F., Tomasevic, L., Gianno, V., Parronchi, P., Romagnani, S. & Maggi, E. (1995), Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-α and interleukin-12. Eur. J. Immunol., 25, 2656-2660.
162. [161] Tite, J.P., Foellmer, H.G., Madri, J.A. & Janeway, C.A. (1987), Inverse Ir gene control of the antibody and T cell proliferative responses to human basement membrane collagen. J. Immunol., 139, 2892-2898.
163. [162] Murray, J.S., Madri, J., Pasqualini, T. & Bottomly, K. (1993), Functional CD4 T cell subset interplay in an intact immune system. J. Immunol., 150, 4270-4276.
164. [163] Murray, J.S., Pfeiffer, C., Madri, J. & Bottomly, K. (1992), Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol., 22, 559-565.
165. [164] Hsieh, C.-S., Macatonia, S.E., O'Garra, A. & Murphy, K.M. (1995), T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med., 181, 713-721.
166. + T cells isolated from different mouse strains. J. Immunol., 155, 3788-3793.
167. + T cells. J. Immunol., 154, 1684-1690.
168. + cells. Eur. J. Immunol., 25, 587-595.
169. [168] Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. & Glimcher, L.H. (1995), B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 80, 707-718.
170. [169] Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.-Y., Rennert, P.D., Gray, G.S., Gribben, J.G. & Nadler, L.M. (1995), B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL4. Immunity, 2, 523-532.
171. [170] Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C. & Bluestone, J.A. (1995), Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med., 181, 1145-1155.
172. [171] Corry, D.B., Reiner, S.L., Linsley, P.S. & Locksley, R.M. (1994), Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental Leishmaniasis. J. Immunol., 153, 4142-4148.
173. [172] Lu, P., di Zhou, X., Chen, S.J., Moorman, M., Morris, S.C., Finkelman, F.D., Linsley, P., Urban, J.F. & Gause, W.C. (1994), CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med., 180, 693-698.
174. + T lymphocytes from TCR transgenic mice. J. Immunol., 152, 5220-5225.
175. [174] Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo Jr., V.A., Lombard, L.A., Gray, G.S. & Nadler, L.M. (1993), Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science, 262, 909-911.
176. [175] Hathcock, K.S., Laszlo, G., Pucillo, C., Linsley, P. & Modes, R.J. (1994), Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med., 180, 631-640.
177. [176] Shu, U., Kiniwa, M., Wu, C.Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M. & Delespesse, G. (1995), Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol., 25, 1125-1128.
178. [177] Stüber, E., Strober, W. & Neurath, M. (1996), Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med., 183, 693-698.
179. [178] Gajewski, T.F., Pinnas, M., Wong, T. & Fitch, F.W. (1991), Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol., 146, 1750-1758.
180. + T cell subsets to Plasmodium chabaudi chabaudi in B-cell-deficient mice. Int. Immunol., 5, 1343-1348.
181. [180] Rossi-Bergmann, B., Müller, I. & Godinho, E.B. (1993), Th1 and Th2 T-cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis. Infect. Immun., 61, 2266-2269.
182. [181] Conradt, P. & Kaufmann, S.H.E. (1995), Impact of antigen-presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect. Imm., 63, 2079-2081.
183. [182] De Becker, G., Sornasse, T., Nabavi, N., Bazin, H., Tieleman, F., Urbain, J., Leo, O. & Moser, M. (1994), Immunoglobulin isotype regulation by antigen-presenting cells in vivo. Eur. J. Immunol., 24, 1523-1528.
184. [183] Ronchese, F., Hausmann, B. & Gros, G.L. (1994), Interferon-γ and interleukin-4-producing T cells can be primed on dendritic cells in vivo and do not require the presence of B cells. Eur. J. Immunol., 24, 1148-1154.
185. [184] Duncan, D.D. & Swain, S.L. (1994), Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol., 24, 2506-2514.
186. [185] Wang, Z.E., Zheng, S., Corry, D.B., Dalton, D.K., Seder, R.A., Reiner, S.L. & Locksley, R.M. (1994), Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA, 91, 12932-12936.
187. + αβ-TCR transgenic T cells is macrophage dependent. Int. Immunol., 5, 371-382.
188. + T cells through IL12 produced by Listeria-induced macrophages. Science, 260, 547-549.
189. + T cells. J. Immunol., 154, 5071-5079.
190. [189] Willems, F., Marchant, A., Delville, J.-P., Gérard, C., Delvaux, A., Velu, T., de Boer, M. & Goldman, M. (1994), Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol., 24, 1007-1009.
191. [190] Plaut, M., Pierce, J.H., Watson, C.J., Hanley-Hyde, J., Nordan, R.P. & Paul, W.E. (1989), Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature (Lond.), 339, 64-67.
192. [191] Lamkhioued, B., Aldebert, D., Gounni, A.S., Delaporte, E., Goldman, M., Capron, A. & Capron, M. (1995), Synthesis of cytokines by eosinophils and their regulation. Int. Arch. Allergy Immunol., 107, 122-123.
193. [191 bis] Ting, S., Meng, Q., Taborda-Barata, L., Corrigan, C.J., Barkans, J., Assoufi, B., Mobqel, R., Durham, S.R., Kay, A.B. (1996), Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur. J. Immunol., 26, 70-76.
194. [192] Kunkel, S.L., Strieter, R.M., Lindley, I.J.D. & Westwick, J. (1995), Chemokines: new ligands, receptors and activities. Immunol. Today, 16, 559-561.
195. [193] Taub, D.D., Ortaldo, J.R., Turcovski-Corrales, S.M., Key, M.L., Longo, D.L. & Murphy, W.J. (1996), β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukocyte. Biol., 59, 81-89.
196. [194] Le Gros, G., Ben-Sasson, S.Z., Seder, R., Finkelman, F.D. & Paul, W.E. (1990), Generation of interleukin 4 (IL4)-producing cells in vivo and in vitro: IL2 and IL4 are required for in vitro generation of IL4-producing cells. J. Exp. Med., 172, 921-929.
197. [195] Swain, S.L., Weinberg, A.D., English, M. & Huston, G. (1990), IL4 directs the development of Th2-like helper effectors. J. Immunol., 145, 3796-3806.
198. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med., 179, 1285-1295.
199. + T cells in a Th2 response and in immunoglobulin E production. Science, 270, 1845-1847.
200. + T cells: a new family of T cells. Immunol. Today, 17, 71-76.
201. -. Eur. J. Immunol., 25, 3298-3307.
202. [200] Ferrick, D.A., Schrenzel, M.D., Mulvania, T., Hsieh, B., Ferlin, W.G. & Lepper, H. (1995), Differential production of interferon-γ and interleukin-4 in response to Th1-and Th2-stimulating pathogens by γδ T cells in vivo. Nature (Lond.), 373, 255-257.
203. [201] Ben-Sasson, S.Z., Le Gros, G., Conrad, D.H., Finkelman, F.D. & Paul, W.E. (1990), Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines. Proc. Natl. Acad. Sci USA, 87, 1421-1425.
204. [202] Demeure, C.E., Yang, L.-P., Byun, D.G., Ishihara, H., Vezzio, N. & Delespesse, G. (1995), Human naive CD4 T cells produce interleukin-4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions. Eur. J. Immunol., 25, 2722-2725.
205. [203] Schmitz, J., Thiel, A., Kühn, R., Rajewsky, K., Müller, W., Assenmacher, M. & Radbruch, A. (1994), Induction of interleukin 4 (IL4) expression in T helper (Th) cells is not dependent on IL4 from non-Th cells. J. Exp. Med., 179, 1349-1353.
206. [204] Aoki, I., Kinzer, C., Shirai, A., Paul, W.E. & Klinman, D.M. (1995), IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice. Proc. Natl. Acad. Sci. USA, 92, 2534-2538.
207. [205] Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B. & Trinchieri, G. (1989), Identification and purification of Natural Killer Cell Stimulatory Factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170, 827-845.
208. [206] Wolf, S.F., Temple, P.A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R.M., Kelleher, K., Herrmann, S.H., Clark, S.C., Azzoni, L., Chan, S.H., Trinchieri, G. & Perussia, B. (1991), Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol., 146, 3074-3081.
209. [207] Chan, S.H., Perussia, B., Gupta, J.W., Kobayashi, M., Pospisil, M., Young, H.A., Clark, S.C. & Trinchieri, G. (1991), Induction of interferon γ production by Natural Killer Cell Stimulatory Factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med., 173, 869-879.
210. [208] Aragane, Y., Riemann, H., Bhardwaj, R.S., Schwarz, A., Sawada, Y., Yamada, H., Luger, T.A., Kubin, M., Trinchieri, G. & Schwarz, T. (1994), IL12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J. Immunol., 153, 5366-5372.
211. [209] Cassatella, M.A., Meda, L., Gasperini, S., D'Andrea, A. & Trinchieri, G. (1995), Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol., 25, 1-5.
212. [210] Manetti, R., Parronchi, P., Giudizi, M.G., Piccinni, M.P., Maggi, E., Trinchieri, G. & Romagnani, S. (1993), Natural killer cell stimulatory factor (interleukin 12 (IL12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL4 producing Th cells. J. Exp. Med., 177, 1199-1204.
213. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA., 90, 10188-10192.
214. [212] Biron, C.A. & Gazzinelli, R.T. (1995), Effects of IL12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol., 1, 485-496.
215. [213] Brunda, M.J., Luistro, L., Warrier, R.R., Wright, R.B., Hubbard, B.R., Murphy, M., Wolf, S.F. & Gately, M.K. (1993), Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178, 1223-1230.
216. [214] Perez, V.L., Lederer, J.A., Lichtman, A.H. & Abbas, A.K. (1995), Stability of Th1 and Th2 populations. Int. Immunol., 7, 869-875.
217. [215] Szabo, S.J., Jacobson, N.G., Dighe, A.S., Gubler, U. & Murphy, K.M. (1995), Developmental commitment to the Th2 lineage by extinction of IL12 signaling. Immunity, 2, 665-675.
218. [216] Sedegah, M., Finkelman, F. & Hoffman, S.L. (1994), Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci USA, 91, 10700-10702.
219. [217] Wynn, T.A., Jankovic, D., Hieny, S., Cheever, A.W. & Sher, A. (1995), IL12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol., 154, 4701-4709.
220. [218] Vieira, L.Q., Hondowicz, B.D., Afonso, L.C.C., Wysocka, M., Trinchieri, G. & Scott, P. (1994), Infection with Leishmania major induces interleukin-12 production in vivo. Immunol. Lett., 40, 157-161.
221. [219] Nabors, G.S., Afonso, L.C.C., Farrell, J.P. & Scott, P. (1995), Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combines therapy with interleukin 12 and pentostam. Proc. Natl. Acad. Sci USA, 92, 3142-3146.